However, several studies have shown that PD-L1 expression can be upregulated on various types of tumor cells by the activation of the STAT3 and PI3K-Akt pathways when CXCL9 is stimulated by IFN-gamma signaling [52,53]. The gene discussed is CD274; the disease is neoplasm.